Cas9-directed immune tolerance in humans—a model to evaluate regulatory T cells in gene therapy?
Abstract The dichotomic nature of the adaptive immune response governs the outcome of clinical gene therapy. On the one hand, neutralizing antibodies and cytotoxic T cells can have a dramatic impact on the efficacy and safety of human gene therapies. On the other hand, regulatory T cells (Treg) can...
Gorde:
| Egile Nagusiak: | , , |
|---|---|
| Formatua: | Revisão |
| Hizkuntza: | ingelesa |
| Argitaratua: |
2021
|
| Sarrera elektronikoa: | https://doi.org/10.1038/s41434-021-00232-2 https://www.nature.com/articles/s41434-021-00232-2.pdf |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|